April 26 (Reuters) -
* NOVAVAX :PREPARED TO DELIVER PROTEIN-BASED NON-MRNA JN.1 COVID-19 VACCINE IN LINE WITH WHO RECOMMENDATION THIS FALL
Source text: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;;))
April 26 (Reuters) -
* NOVAVAX :PREPARED TO DELIVER PROTEIN-BASED NON-MRNA JN.1 COVID-19 VACCINE IN LINE WITH WHO RECOMMENDATION THIS FALL
Source text: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;;))
Comments